Novel Antibiotic Shows Promise for Community-Acquired Pneumonia (FREE)

By Amy Orciari Herman Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH Oral solithromycin is noninferior to moxifloxacin for the treatment of community-acquired bacterial pneumonia, according to an industry-funded, phase 3 trial published …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news